TMEM214 and sarcoma: RIPK3, TFAP2E and TMEM214 were good candidates for the non-neural crest tumors since they are mutated in sarcomas (TCGA SARC), myomatous neoplasms and in hepatocarcinomas (TCGA LIHC) at the somatic level.